Xeomin® and Gait Related Mobility After Stroke
Part of paid clinical trials in Charlotte, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT04908423
- Phase
- PHASE4
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 79 Years
- Healthy Volunteers
- Not accepted
Interventions
- Xeomin® — DRUGTo discover whether injection into the upper extremity with Xeomin® triggers improvements in gait-related mobility and quality of life in adults with hemiparesis secondary to stroke.
Study Details
The aim of the present pilot study is to evaluate the association between change in gait related mobility in ambulatory male and female adult hemiparetic patients before and 4-6-weeks after Xeomin® injection into the upper limb, using two standardized tests of physical function in outpatient rehabilitation that are widely used; the 10-meter walk test and the timed 'up and go' test (TUG).
Key Dates
- Start date
- Oct 19, 2021
- Status verified
- Nov 2025
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Xeomin®Participants will be injected via electromyographic guidance with a total of 200 units of Xeomin® into the pectoralis major, biceps brachii, brachioradialis, and latissimus dorsi muscles of the hemiparetic side using a standardized injection protocol (16). An additional 100 units of Xeomin® will be available at the discretion of the investigator for injection into additional affected upper extremity muscles
Primary Outcome Measure
Change in Instrumented Timed Up and Go test time [ Time Frame: Baseline and 4-6 weeks after Xeomin injection ]
Central Contacts
- Mark A Hirsch, PhD704-355-7673
- Kiandra Austrie, RN, BSN704-355-1525
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Carolinas Rehabilitation | Charlotte | North Carolina | 28203 | Mark A Hirsch, PhD (PRINCIPAL_INVESTIGATOR) Nathan Darji, BS, DO (SUB_INVESTIGATOR) Sima Desai, MS, BS, MD (SUB_INVESTIGATOR) Leon Chandler, MD (SUB_INVESTIGATOR) |
Find similar trials in Charlotte, NC
By condition
By specialty
By research site
Related Studies
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama